JRI
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
JRI - overview
Established
1845
Location
-, fesches-le-châtel, France
Primary Industry
Medical Devices & Equipment
About
JRI, based in Bezons, France since 1845, specializes in advanced monitoring systems for temperature and humidity, serving sectors like pharmaceuticals and healthcare with precise calibration and compliance solutions. Founded in 1845, JRI provides innovative monitoring solutions. The company has maintained a consistent focus on delivering accuracy in environmental monitoring for various industries. Recently, in September 2023, IK Partners acquired JRI from Naxicap Partners, marking a significant transition in ownership.
JRI specializes in the design, manufacturing, and calibration of advanced monitoring systems for temperature and humidity, primarily targeting the pharmaceutical, healthcare, and food industries. Their product lineup includes wireless temperature monitoring systems like JRI-MySirius, Naocom, and Verigo, which assist end-users such as hospitals and logistics companies in meeting compliance with traceability regulations by providing real-time data on environmental conditions during transport and storage of sensitive products. In 2022, JRI reported a revenue of USD 22. 71 mn and an EBITDA of USD 5.
02 mn. The company generates revenue through direct sales to B2B clients, including installation, calibration, and ongoing technical support. Their pricing structure accommodates various product complexities, offering both entry-level and advanced monitoring solutions, along with subscription-based services for continued support and updates. JRI is focused on expanding its market reach and enhancing its product offerings.
The company has plans to launch new products aimed at improving monitoring capabilities and is targeting expansion into additional markets across Europe and Asia by 2025. The recent acquisition by IK Partners will provide the necessary resources to fuel these initiatives, positioning JRI for future growth.
Current Investors
Naxicap Partners, Metrology & Monitoring Solutions group
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Supplies
Website
www.jri.fr/
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
JRI - timeline of key events

JRI - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 10,557,103 | 11,062,445 | - | 12,269,048 | 12,714,065 | 12,125,109 | - | - | - |
| % Revenue Growth (YoY) | - | 4.8% | - | - | 3.6% | (4.6%) | - | - | - |
| EBITDA (USD) | 453,506 | 863,914 | - | 1,452,221 | 1,513,123 | 1,388,346 | - | - | - |
| Operating Income (USD) | 289,800 | 669,253 | - | 1,295,771 | 1,310,393 | 1,132,700 | - | - | - |
| Operating Margin | 2.7% | 6.0% | - | 10.6% | 10.3% | 9.3% | - | - | - |
| % EBITDA Margin | 4.3% | 7.8% | - | 11.8% | 11.9% | 11.5% | - | - | - |
| NET Income (USD) | 617,425 | 721,434 | - | 985,681 | 1,004,752 | 973,562 | - | - | - |
| % Net Margin | 5.8% | 6.5% | - | 8.0% | 7.9% | 8.0% | - | - | - |
JRI - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | JRI | - | ||||||||
| Buyout | Completed | JRI | - | ||||||||
| Add-on | Completed | JRI | - |
Displaying 1 - 3 of 3
JRI - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.